
|Articles|November 1, 2006
Breast cancer risk in subset of OC users
Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Remnant cholesterol linked to endometriosis risk
2
IV iron dextran found cost-effective as first-line treatment for IDA in heavy menstrual bleeding
3
Contemporary OB/GYN week in review: opioid use, COVID-19 vaccine, and more
4
Maternal influenza and Tdap vaccination linked to fewer infant hospital and emergency visits
5











